Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring

U Tröger, A Drust, J Martens-Lobenhoffer… - International journal of …, 2012 - Elsevier
One of the first-line drugs for empirical antibiotic therapy in patients with hospital-acquired
infections is meropenem. An often neglected problem in sepsis is that patients with a normal …

Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney …

MP Pai, P Cojutti, F Pea - Clinical pharmacokinetics, 2015 - Springer
Background Meropenem is an anti-Gram-negative antimicrobial, the time-dependent activity
of which may be maximized through administration by continuous infusion. Objectives The …

Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: validation of clinical trial simulations

EJ Nehus, T Mizuno, S Cox… - The Journal of …, 2016 - Wiley Online Library
Meropenem is frequently prescribed in critically ill children receiving continuous renal
replacement therapy (CRRT). We previously used clinical trial simulations to evaluate …

[HTML][HTML] Physiologically based pharmacokinetic-pharmacodynamic evaluation of meropenem in CKD and hemodialysis individuals

G Deng, F Yang, N Sun, D Liang, A Cen… - Frontiers in …, 2023 - frontiersin.org
Objective: Chronic kidney disease (CKD) has significant effects on renal clearance of drugs.
The application of antibiotics in CKD patients to achieve the desired therapeutic effect is …

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

I Tegeder, F Neumann, F Bremer… - Clinical …, 1999 - Wiley Online Library
Objective Meropenem is a broad‐spectrum antibiotic used for severe infections. In patients
with chronic end‐stage renal failure, meropenem clearance is reduced and doses must be …

Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration

TFT Ververs, A van Dijk, SA Vinks… - Critical care …, 2000 - journals.lww.com
Pharmacokinetics and dosing regimen of meropenem in critical... : Critical Care Medicine
Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving …

Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review

J Perrott, VH Mabasa… - Annals of …, 2010 - journals.sagepub.com
Objective: To systematically review evidence comparing traditional and alternative dosing
strategies for meropenem, based on clinical and pharmacoeconomic outcomes. Data …

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor… - International journal of …, 2015 - Elsevier
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …

Outcome evaluation of an intervention to improve the effective and safe use of meropenem

Y Yagi, M Okazaki, H Higaki, M Nakai, A Hirata… - International journal of …, 2014 - Springer
Background Pharmacists have been involved in promoting the proper and safe use of
antimicrobial drugs in our institution since 2010. Setting Kochi Medical School Hospital …

Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study

Y Wang, Z Li, W Chen, G Yan, G Wang… - Journal of Clinical …, 2021 - Wiley Online Library
What is known and Objective Meropenem, a broad‐spectrum carbapenem, is frequently
used to treat severe bacterial infections in critically ill children. Recommendations for …